197 related articles for article (PubMed ID: 26145450)
1. Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.
Puvvada N; Rajput S; Kumar BNP; Sarkar S; Konar S; Brunt KR; Rao RR; Mazumdar A; Das SK; Basu R; Fisher PB; Mandal M; Pathak A
Sci Rep; 2015 Jul; 5():11760. PubMed ID: 26145450
[TBL] [Abstract][Full Text] [Related]
2. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
Ajorlou E; Khosroushahi AY; Yeganeh H
Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy.
Xiao Y; Wang S; Zong Q; Yin Z
AAPS PharmSciTech; 2018 Jul; 19(5):2395-2406. PubMed ID: 29869309
[TBL] [Abstract][Full Text] [Related]
5. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
7. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
Al Faraj A; Shaik AS; Ratemi E; Halwani R
J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662
[TBL] [Abstract][Full Text] [Related]
8. Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly.
Fu Q; Wang Y; Ma Y; Zhang D; Fallon JK; Yang X; Liu D; He Z; Liu F
Sci Rep; 2015 Jul; 5():12023. PubMed ID: 26166066
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of breast cancer metastasis by paclitaxel-loaded pH responsive poly(β-amino ester) copolymer micelles.
Chen Y; Yue Q; De G; Wang J; Li Z; Xiao S; Yu H; Ma H; Sui F; Zhao Q
Nanomedicine (Lond); 2017 Jan; 12(2):147-164. PubMed ID: 27854565
[TBL] [Abstract][Full Text] [Related]
10. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Sadhukhan P; Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():129-140. PubMed ID: 30948047
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
13. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
14. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
[TBL] [Abstract][Full Text] [Related]
15. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.
Gao Y; Li Y; Li Y; Yuan L; Zhou Y; Li J; Zhao L; Zhang C; Li X; Liu Y
Nanoscale; 2015 Jan; 7(2):597-612. PubMed ID: 25419788
[TBL] [Abstract][Full Text] [Related]
16. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model.
Piao L; Li Y; Zhang H; Jiang J
J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090
[TBL] [Abstract][Full Text] [Related]
17. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
18. Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer.
Tang S; Meng Q; Sun H; Su J; Yin Q; Zhang Z; Yu H; Chen L; Gu W; Li Y
Biomaterials; 2017 Jan; 114():44-53. PubMed ID: 27842234
[TBL] [Abstract][Full Text] [Related]
19. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
20. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
